Table 2.
Patient and radiation treatment characteristics across selected trials.
| authors | surgery |
fractionation |
boost (%) | bolus (%) | ||
|---|---|---|---|---|---|---|
| lumpectomy (%) | mastectomy (%) | CF (%) | mHF (%) | |||
| Herst et al. | 56 | 44 | 50 | 50 | 36 | 8 |
| Schmeel et al. (a) | 100 | 0 | 100 | 0 | 31 | 0 |
| Møller et al. | 80 | 20 | 25 | 75 | 8 | 20 |
| Schmeel et al. (b) | 100 | 0 | 0 | 100 | 34 | 0 |
| Behroozian et al. | 58a | 42 | 7 | 93 | 29 | 13 |
| total | 79 | 21 | 36 | 64 | 27 | 8 |
CF = conventional fractionation; mHF = moderate hypofractionation.
a
In this trial, only patients at a higher risk of developing radiation dermatitis were included. Therefore, patients were only eligible after lumpectomy if they had a postoperative bra size ≥36 inches or cup size ≥ C.